Quality

Apr 27, 2016
By Pharmaceutical Technology Editors
The company voluntarily recalls product due to particulate matter.
Apr 14, 2016
By Pharmaceutical Technology Editors
The company has recalled one lot of 50% magnesium sulfate injection, USP due to particulates.
Apr 02, 2016
Pharmaceutical Technology
Pharmaceutical Technology spoke with FDA to get the agency’s insights on how the industry can ensure quality in solid and semi-solid dosage products.
Apr 02, 2016
Pharmaceutical Technology
Visible residue limits have been shown to be a valuable tool in validated cleaning validation program.
Apr 02, 2016
Pharmaceutical Technology
Understanding of the risks associated with FMEA is crucial in lot release testing.
Apr 02, 2016
Pharmaceutical Technology
Industry experts and FDA’s Office of Pharmaceutical Quality discuss the challenges, trends, and regulations involved in ensuring quality in solid and semi-solid dosage forms.
Mar 21, 2016
By Pharmaceutical Technology Editors
Hospira recalls one lot of 8.4% Sodium Bicarbonate Injection, USP, due to particulate matter found within a single-dose glass fliptop vial.
Mar 15, 2016
Pharmaceutical Technology eBooks
The authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
Mar 15, 2016
Pharmaceutical Technology eBooks
The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.
Mar 07, 2016
By Pharmaceutical Technology Editors
Sagent Pharmaceuticals issues a nationwide recall of Fluconazole injection, USP, due to out of specification impurity results.
lorem ipsum